Blocking VRK2 suppresses pulmonary adenocarcinoma progression via ERK1/2/AKT signal pathway by targeting miR-145-5p.
- DOI
- 10.26355/eurrev_202101_24378
- Published
- 2021 Jan
- Container
- European review for medical and pharmacological sciences
- Publisher
- Not recorded
- Open access
- no
Credibility signals
serious concern Score 8/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- serious concernRetraction Watch retraction: 1 retraction notice matched this DOI.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.26355/eurrev_202101_24378,
title = {Blocking VRK2 suppresses pulmonary adenocarcinoma progression via ERK1/2/AKT signal pathway by targeting miR-145-5p.},
author = {Mu Y and Liu WJ and Bie LY and Mu XQ and Zhao YQ},
year = {2021},
journal = {European review for medical and pharmacological sciences},
doi = {10.26355/eurrev_202101_24378},
url = {https://doi.org/10.26355/eurrev_202101_24378}
}RIS
TY - JOUR TI - Blocking VRK2 suppresses pulmonary adenocarcinoma progression via ERK1/2/AKT signal pathway by targeting miR-145-5p. AU - Mu Y AU - Liu WJ AU - Bie LY AU - Mu XQ AU - Zhao YQ PY - 2021 JO - European review for medical and pharmacological sciences DO - 10.26355/eurrev_202101_24378 UR - https://doi.org/10.26355/eurrev_202101_24378 ER -
APA
Y, M., WJ, L., LY, B., XQ, M., & YQ, Z. (2021). Blocking VRK2 suppresses pulmonary adenocarcinoma progression via ERK1/2/AKT signal pathway by targeting miR-145-5p.. European review for medical and pharmacological sciences. https://doi.org/10.26355/eurrev_202101_24378
Source records
- pubmed · retrieved 2026-09-25T11:46:22.614Z
- europe-pmc · retrieved 2026-09-25T11:46:22.624Z
- europe-pmc · retrieved 2026-09-25T11:46:22.624Z